Literature DB >> 26976412

Is It Time to Redefine Prognostic and Predictive in Oncology?

Mark Minden1.   

Abstract

Mesh：

Year:  2016        PMID： 26976412     DOI： 10.1200/JCO.2015.66.3815

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Reply to the Correspondence by Untch et al. "Concerning Dediu M, Zielinski C: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer" [Breast Care 2019; DOI 10.1159/000500624].

Authors:  Mircea Dediu; Christoph Zielinski
Journal:  Breast Care (Basel)       Date:  2019-08-29       Impact factor: 2.860

Review 2.  The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Authors:  Gianluca Gaidano; Davide Rossi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.

Authors:  Eric Ojerholm; Andrew Smith; Wei-Ting Hwang; Brian C Baumann; Kai N Tucker; Seth P Lerner; Ronac Mamtani; Ben Boursi; John P Christodouleas
Journal:  Cancer       Date:  2016-10-27       Impact factor: 6.860

4.  Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC.

Authors:  Yiting Sun; Jianchun Duan; Wenfeng Fang; Zhijie Wang; Xinyang Du; Xin Wang; Chengcheng Li; Shangli Cai; Jie Zhao; Sini Li; Li Zhang; Hua Bai; Jie Wang
Journal:  BMC Med       Date:  2021-10-07       Impact factor: 8.775

Review 5.  Druggable Molecular Pathways in Chronic Lymphocytic Leukemia.

Authors:  Mohammad Almasri; Marah Amer; Joseph Ghanej; Abdurraouf Mokhtar Mahmoud; Gianluca Gaidano; Riccardo Moia
Journal:  Life (Basel)       Date:  2022-02-14

Review 6.  Impact of Low-Burden TP53 Mutations in the Management of CLL.

Authors:  Gregory Lazarian; Florence Cymbalista; Fanny Baran-Marszak
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.